Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Latium And NotA. Dürr

List of bibliographic references

Number of relevant bibliographic references: 86.
Ident.Authors (with country if any)Title
000072 Letterio Morgante [Italie] ; Carlo Colosimo [Italie] ; Angelo Antonini [Italie] ; Roberto Marconi [Italie] ; Giuseppe Meco [Italie] ; Massimo Pederzoli [Italie] ; Francesco E. Pontieri [Italie] ; Giulio Cicarelli [Italie] ; Giovanni Abbruzzese [Italie] ; Salvatore Zappulla [Italie] ; Silvia Ramat [Italie] ; Michela Manfredi [Italie] ; Edo Bottacchi [Italie] ; Michele Abrignani [Italie] ; Alfredo Berardelli [Italie] ; Autilia Cozzolino [Italie] ; Claudio Paradiso [Italie] ; Danilo De Gaspari [Italie] ; Francesca Morgante [Italie] ; Paolo Barone [Italie]Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression
000140 Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Ad Theeuwes [Pays-Bas] ; Fabrizio Stocchi [Italie] ; Joaquim J. Ferreira [Portugal] ; Serge Van De Witte [Pays-Bas] ; Juliana Bronzova [Pays-Bas]Temporal stability of the Unified Dyskinesia Rating Scale
000171 S. Giaquinto [Italie] ; L. Bruti [Italie] ; V. Dall'Armi [Italie] ; E. Palma [Italie] ; C. Spiridigliozzi [Italie]Religious and spiritual beliefs in outpatients suffering from Parkinson Disease
000213 Fabrizio Stocchi [Italie] ; Luigi Giorgi [Royaume-Uni] ; Brian Hunter [Royaume-Uni] ; Anthony Hv Schapira [Royaume-Uni]PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease
000230 Lucia Frau [Italie] ; Franco Borsini [Italie] ; Jadwiga Wardas [Pologne] ; Amit S. Khairnar [Italie] ; Nicoletta Schintu [Italie] ; Micaela Morelli [Italie]Neuroprotective and anti‐inflammatory effects of the adenosine A2A receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease
000239 Davide Chiasserini [Italie] ; Alessandro Tozzi [Italie] ; Antonio De Iure [Italie] ; Michela Tantucci [Italie] ; Federica Susta [Italie] ; Pier Luigi Orvietani [Italie] ; Keizo Koya [États-Unis] ; Luciano Binaglia [Italie] ; Paolo Calabresi [Italie]Mortalin inhibition in experimental Parkinson's disease
000243 Alfonso Fasano [Allemagne, Italie] ; Jan Herzog [Allemagne] ; Elena Seifert [Allemagne] ; Henning Stolze [Allemagne] ; Daniela Falk [Allemagne] ; René Reese [Allemagne] ; Jens Volkmann [Allemagne] ; Günther Deuschl [Allemagne]Modulation of gait coordination by subthalamic stimulation improves freezing of gait
000266 R. Ceravolo ; L. Brusa [Italie] ; S. Galati [Italie] ; D. Volterrani ; A. Peppe [Italie] ; G. Siciliano ; M. Pierantozzi [Italie] ; V. Moschella [Italie] ; U. Bonuccelli ; P. Stanzione [Italie] ; A. Stefani [Italie]Low frequency stimulation of the nucleus tegmenti pedunculopontini increases cortical metabolism in Parkinsonian patients
000273 E. Pascale [Italie] ; E. Passarelli [Italie] ; C. Purcaro [Italie] ; A. R. Vestri [Italie] ; A. Fakeri [Italie] ; R. Guglielmi [Italie] ; F. Passarelli [Italie] ; G. Meco [Italie]Lack of association between IL‐1β, TNF‐α, and IL‐10 gene polymorphisms and sporadic Parkinson’s disease in an Italian cohort
000316 Armando Perrotta [Italie] ; Giorgio Sandrini [Italie] ; Mariano Serrao [Italie] ; Simona Buscone [Italie] ; Cristina Tassorelli [Italie] ; Michele Tinazzi [Italie] ; Roberta Zangaglia [Italie] ; Claudio Pacchetti [Italie] ; Michelangelo Bartolo [Italie] ; Francesco Pierelli [Italie] ; Emilia Martignoni [Italie]Facilitated temporal summation of pain at spinal level in Parkinson's disease
000328 F. Stocchi [Italie] ; J. M. Rabey [Israël]Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson’s disease
000373 Lucilla Parnetti [Italie] ; Davide Chiasserini [Italie] ; Gianni Bellomo [Italie] ; David Giannandrea [Italie] ; Claudia De Carlo [Italie] ; Mohamed M. Qureshi [Émirats arabes unis] ; Mustafa T. Ardah [Émirats arabes unis] ; Shiji Varghese [Émirats arabes unis] ; Laura Bonanni [Italie] ; Barbara Borroni [Italie] ; Nicola Tambasco [Italie] ; Paolo Eusebi [Italie] ; Aroldo Rossi [Italie] ; Marco Onofrj [Italie] ; Alessandro Padovani [Italie] ; Paolo Calabresi [Italie] ; Omar El-Agnaf [Émirats arabes unis]Cerebrospinal fluid Tau/α‐synuclein ratio in Parkinson's disease and degenerative dementias
000395 Francesca Assogna [Italie] ; Luca Cravello [Italie] ; Carlo Caltagirone [Italie] ; Gianfranco Spalletta [Italie]Anhedonia in Parkinson's disease: A systematic review of the literature
000414 N. Tambasco ; V. Belcastro [Italie] ; P. Sarchielli ; P. Floridi ; L. Pierguidi [Italie] ; C. Menichetti [Italie] ; A. Castrioto ; P. Chiarini ; L. Parnetti ; P. Eusebi [Italie] ; P. Calabresi [Italie] ; A. RossiA magnetization transfer study of mild and advanced Parkinson’s disease
000434 Antonella Conte [Italie] ; Nicola Modugno [Italie] ; Francesco Lena [Italie] ; Sabrina Dispenza [Italie] ; Barbara Gandolfi [Italie] ; Ennio Iezzi [Italie] ; Giovanni Fabbrini [Italie] ; Alfredo Berardelli [Italie]Subthalamic nucleus stimulation and somatosensory temporal discrimination in Parkinsons disease
000456 Patrice Pran [Italie, France] ; Andrea Cherubini [Italie] ; Francesca Assogna [Italie] ; Fabrizio Piras [Italie] ; Carlo Quattrocchi [Italie] ; Antonella Peppe [Italie] ; Pierre Celsis [France] ; Olivier Rascol [France] ; Jean-Franois Dmonet [France] ; Alessandro Stefani [Italie] ; Mariangela Pierantozzi [Italie] ; Francesco Ernesto Pontieri [Italie] ; Carlo Caltagirone [Italie] ; Gianfranco Spalletta [Italie] ; Umberto Sabatini [Italie]Magnetic resonance imaging markers of Parkinsons disease nigrostriatal signature
000516 K. Ray Chaudhuri [Royaume-Uni] ; Cristina Prieto-Jurcynska [Espagne] ; Yogini Naidu [Royaume-Uni] ; Tanya Mitra [Royaume-Uni] ; Belen Frades-Payo [Espagne] ; Susanne Tluk [Royaume-Uni] ; Anne Ruessmann [Allemagne] ; Per Odin [Allemagne] ; Graeme Macphee [Royaume-Uni] ; Fabrizio Stocchi [Italie] ; William Ondo [États-Unis] ; Kapil Sethi [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Juan Carlos Martinez Castrillo [Espagne] ; Pablo Martinez-Martin [Espagne]The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the nonmotor symptoms questionnaire
000530 Carlo Colosimo [Italie] ; Pablo Martínez-Martín [Espagne] ; Giovanni Fabbrini [Italie] ; Robert A. Hauser [États-Unis] ; Marcelo Merello [Argentine] ; Janis Miyasaki [Canada] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] ; Christopher G. Goetz [États-Unis]Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations
000549 Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne]Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study
000655 Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Pierre Pollak [France] ; Yves Agid [France] ; Stig Rehncrona [Suède] ; Jens Volkmann [Allemagne] ; Jaime Kulisevsky [Espagne] ; Jose A. Obeso [Espagne] ; Alberto Albanese [Italie] ; Marwan I. Hariz [Royaume-Uni, Suède] ; Niall P. Quinn [Royaume-Uni] ; Jans D. Speelman [Pays-Bas] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Alexandre Mendes [France] ; Marie-Laure Welter [France] ; Jean-Luc Houeto [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Annalena L. Tornqvist [Suède] ; Ron Ekberg [Suède] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Lars Wojtecki [Allemagne] ; Andres Gironell [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Jorge Guridi [Espagne] ; Anna R. Bentivoglio [Italie] ; Maria F. Contarino [Italie, Pays-Bas] ; Luigi Romito [Italie] ; Massimo Scerrati [Italie] ; Marc Janssens [Pays-Bas] ; Anthony E. Lang [Canada]Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease
000668 Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Karl Kieburtz [États-Unis] ; Werner Poewe [Autriche] ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa [Espagne] ; Paulo Barone [Italie] ; Anthony E. Lang [Canada] ; C. Warren Olanow [Italie, États-Unis]Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study
000688 V. Belcastro [Italie] ; L. Pierguidi [Italie] ; A. Castrioto [Italie] ; C. Menichetti [Italie] ; G. Gorgone [Italie] ; R. Ientile ; F. Pisani [Italie] ; A. Rossi [Italie] ; P. Calabresi [Italie] ; N. Tambasco [Italie]Hyperhomocysteinemia recurrence in levodopa‐treated Parkinson’s disease patients
000712 Michelangelo Bartolo [Italie] ; Mariano Serrao [Italie] ; Cristina Tassorelli [Italie] ; Romildo Don [Italie] ; Alberto Ranavolo [Italie] ; Francesco Draicchio [Italie] ; Claudio Pacchetti [Italie] ; Simona Buscone [Italie] ; Armando Perrotta [Italie] ; Anna Furnari [Italie] ; Placido Bramanti [Italie] ; Luca Padua [Italie] ; Francesco Pierelli [Italie] ; Giorgio Sandrini [Italie]Four‐week trunk‐specific rehabilitation treatment improves lateral trunk flexion in Parkinson's disease
000740 Francesco E. Pontieri [Italie] ; Carlo Colosimo [Italie]Dopaminergic system in peripheral blood mononuclear cells in Parkinson's disease
000757 C. Warren Olanow [États-Unis, Italie] ; Karl Kieburtz [États-Unis]Defining disease‐modifying therapies for PD—A road map for moving forward
000796 Elisa Iacovelli [Italie] ; Francesca Gilio [Italie] ; Giuseppe Meco [Italie] ; Francesco Fattapposta [Italie] ; Nicola Vanacore [Italie] ; Livia Brusa [Italie] ; Elena Giacomelli [Italie] ; Maria Gabriele [Italie] ; Alfonso Rubino [Italie] ; Nicoletta Locuratolo [Italie] ; Cesare Iani [Italie] ; Floriana Pichiorri [Italie] ; Carlo Colosimo [Italie] ; Antonio Carbone [Italie] ; Giovanni Palleschi [Italie] ; Maurizio Inghilleri [Italie]Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease
000915 Nir Giladi [Israël] ; Joseph Tal [Israël] ; Tali Azulay [Israël] ; Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Eldad Melamed [Israël] ; Wolfgang Oertel [Allemagne] ; Werner Poewe [Autriche] ; Fabrizio Stocchi [Italie] ; Eduardo Tolosa [Espagne]Validation of the freezing of gait questionnaire in patients with Parkinson's disease
000925 Livia Brusa [Italie] ; Antonio Orlacchio [Italie] ; Vincenzo Moschella [Italie] ; Cesare Iani [Italie] ; Giorgio Bernardi [Italie] ; Nicola Biagio Mercuri [Italie]Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine
000941 Giovanni Defazio [Italie] ; Mar Matarin [États-Unis] ; Elizabeth L. Peckham [États-Unis] ; Davide Martino [Italie] ; Enza M. Valente [Italie] ; Andrew Singleton [États-Unis] ; Anthony Crawley [États-Unis] ; Maria Stella Aniello [Italie] ; Francesco Brancati [Italie] ; Giovanni Abbruzzese [Italie] ; Paolo Girlanda [Italie] ; Paolo Livrea [Italie] ; Mark Hallett [États-Unis] ; Alfredo Berardelli [Italie]The TOR1A polymorphism rs1182 and the risk of spread in primary blepharospasm
000942 Paolo Barone [Italie] ; Angelo Antonini [Italie] ; Carlo Colosimo [Italie] ; Roberto Marconi [Italie] ; Letterio Morgante [Italie] ; Tania P. Avarello [Italie] ; Eugenio Bottacchi [Italie] ; Antonino Cannas [Italie] ; Gabriella Ceravolo [Italie] ; Roberto Ceravolo [Italie] ; Giulio Cicarelli [Italie] ; Roberto M. Gaglio [Italie] ; Rosa M. Giglia [Italie] ; Francesco Iemolo [Italie] ; Michela Manfredi [Italie] ; Giuseppe Meco [Italie] ; Alessandra Nicoletti [Italie] ; Massimo Pederzoli [Italie] ; Alfredo Petrone [Italie] ; Antonio Pisani [Italie] ; Francesco E. Pontieri [Italie] ; Rocco Quatrale [Italie] ; Silvia Ramat [Italie] ; Rosanna Scala [Italie] ; Giuseppe Volpe [Italie] ; Salvatore Zappulla [Italie] ; Anna Rita Bentivoglio [Italie] ; Fabrizio Stocchi [Italie] ; Giorgio Trianni [Italie] ; Paolo Del Dotto [Italie]The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease
000944 Paolo Mazzone [Italie] ; Angelo Insola [Italie] ; Stefano Sposato ; Eugenio Scarnati [Italie]The Deep Brain Stimulation of the Pedunculopontine Tegmental Nucleus
000970 Luigi M. Romito [Italie] ; Maria Fiorella Contarino [Italie] ; Nicola Vanacore [Italie] ; Anna Rita Bentivoglio [Italie] ; Massimo Scerrati [Italie] ; Alberto Albanese [Italie]Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: Long‐term observation
000A11 Giovanni Fabbrini [Italie] ; Giovanni Defazio [Italie] ; Carlo Colosimo [Italie] ; Antonio Suppa [Italie] ; Maria Bloise [Italie] ; Alfredo Berardelli [Italie]Onset and spread of dyskinesias and motor symptoms in Parkinson's disease
000A12 Alessandro Ferraris [Italie] ; Tamara Ialongo [Italie] ; Giulio Cesare Passali [Italie] ; Maria Teresa Pellecchia [Italie] ; Livia Brusa [Italie] ; Marianna Laruffa [Italie] ; Arianna Guidubaldi [Italie] ; Gaetano Paludetti [Italie] ; Alberto Albanese [Italie] ; Paolo Barone [Italie] ; Bruno Dallapiccola [Italie] ; Enza Maria Valente [Italie] ; Anna Rita Bentivoglio [Italie]Olfactory dysfunction in Parkinsonism caused by PINK1 mutations
000A45 Jens Volkmann [Allemagne] ; Alberto Albanese [Italie] ; Jaime Kulisevsky [Espagne] ; Aana-Lena Tornqvist [Suède] ; Jean-Luc Houeto [France] ; Bernard Pidoux [France] ; Anne-Marie Bonnet [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Nadege Van Blercom [France] ; Jing Xie [France] ; José Obeso [Espagne] ; Maria Cruz Rodriguez-Oroz [Espagne] ; Jurge Guridi [Espagne] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Alexandre A. Gironell [Espagne] ; Juan Molet [Espagne] ; Benta Pascual-Sedano [Espagne] ; Stig Rehncrona [Suède] ; Elena Moro [Canada] ; Anthony C. Lang [Canada] ; Andres M. Lozano [Canada] ; Anna Rita Bentivoglio [Italie] ; Massimo Scerrati [Italie] ; Maria Fiorella Contarino [Pays-Bas] ; Luigi Romito [Italie] ; Marc Janssens [Pays-Bas] ; Yves Agid [France]Long‐term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease
000B23 Roberta Zangaglia [Italie] ; Claudio Pacchetti [Italie] ; Chiara Pasotti [Italie] ; Francesca Mancini [Italie] ; Domenico Servello [Italie] ; Elena Sinforiani [Italie] ; Silvano Cristina [Italie] ; Marco Sassi [Italie] ; Giuseppe Nappi [Italie]Deep brain stimulation and cognitive functions in Parkinson's disease: A three‐year controlled study
000B49 D. Tiple [Italie] ; G. Fabbrini [Italie] ; C. Colosimo [Italie] ; D. Ottaviani [Italie] ; F. Camerota [Italie] ; G. Defazio [Italie] ; A. Berardelli [Italie]Camptocormia in Parkinson disease: an epidemiological and clinical study
000B60 F. R. Guerini [Italie] ; E. Beghi [Italie] ; G. Riboldazzi ; R. Zangaglia ; C. Pianezzola ; G. Bono ; C. Casali [Italie] ; C. Di Lorenzo [Italie] ; C. Agliardi [Italie] ; G. Nappi [Italie] ; M. Clerici [Italie] ; E. Martignoni [Italie]BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson’s disease
000B72 Donald Grosset [Royaume-Uni] ; Angelo Antonini [Italie] ; Margherita Canesi [Italie] ; Gianni Pezzoli [Italie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Karen Shaw [Royaume-Uni] ; Esther Cubo [Espagne] ; Pablo Martinez-Martin [Espagne] ; Olivier Rascol [France] ; Laurence Negre-Pages [France] ; Ana Senard [France] ; Johannes Schwarz [Allemagne] ; Karl Strecker [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne] ; Matthias Löhle [Allemagne] ; Fabrizio Stocchi [Italie] ; Katherine Grosset [Royaume-Uni]Adherence to antiparkinson medication in a multicenter European study
000C36 Fabrizio Stocchi [Italie] ; Michele Tagliati [États-Unis] ; C. Warren Olanow [États-Unis]Treatment of levodopa‐induced motor complications
000C94 Eleonora Bazzini [Italie] ; Alberta Samuele [Italie] ; Marcella Granelli [Italie] ; Giovanna Levandis [Italie] ; Marie-Therese Armentero [Italie] ; Giuseppe Nappi [Italie] ; Fabio Blandini [Italie]Proteasomal inhibition and apoptosis regulatory changes in human isolated lymphocytes: The synergistic role of dopamine
000D20 Roberta Marongiu [Italie] ; Alessandro Ferraris [Italie] ; Tàmara Ialongo [Italie] ; Silvia Michiorri [Italie] ; Francesco Soleti [Italie] ; Francesca Ferrari [Italie] ; Antonio E. Elia [Italie] ; Daniele Ghezzi [Italie] ; Alberto Albanese [Italie] ; Maria Concetta Altavista [Italie] ; Angelo Antonini [Italie] ; Paolo Barone [Italie] ; Livia Brusa [Italie] ; Pietro Cortelli [Italie] ; Paolo Martinelli [Italie] ; Maria Teresa Pellecchia [Italie] ; Gianni Pezzoli [Italie] ; Cesa Scaglione [Italie] ; Paolo Stanzione [Italie] ; Michele Tinazzi [Italie] ; Anna Zecchinelli [Italie] ; Massimo Zeviani [Italie] ; Emanuele Cassetta [Italie] ; Barbara Garavaglia [Italie] ; Bruno Dallapiccola [Italie] ; Anna Rita Bentivoglio [Italie] ; Enza Maria Valente [Italie]PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum
000D64 Vania Gelmetti [Italie] ; Alessandro Ferraris [Italie] ; Livia Brusa [Italie] ; Francesca Romano [Italie] ; Federica Lombardi [Italie] ; Chiara Barzaghi [Italie] ; Paolo Stanzione [Italie] ; Barbara Garavaglia [Italie] ; Bruno Dallapiccola [Italie] ; Enza Maria Valente [Italie]Late onset sporadic Parkinson's disease caused by PINK1 mutations: Clinical and functional study
000E78 C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France]A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics
000F13 Roberta Marongiu [Italie] ; Francesco Brancati [Italie] ; Angelo Antonini [Italie] ; Tamara Ialongo [Italie] ; Caterina Ceccarini [Italie] ; Oronzo Scarciolla [Italie] ; Anna Capalbo [Italie] ; Riccardo Benti [Italie] ; Gianni Pezzoli [Italie] ; Bruno Dallapiccola [Italie] ; Stefano Goldwurm [Italie] ; Enza Maria Valente [Italie]Whole gene deletion and splicing mutations expand the PINK1 genotypic spectrum
000F27 Fabio Blandini [Italie] ; Giovanna Levandis [Italie] ; Eleonora Bazzini [Italie] ; Giuseppe Nappi [Italie] ; Marie-Therese Armentero [Italie]Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues from an old model
000F35 Nadia Rosenthal [Italie] ; Steve Brown [Royaume-Uni]The mouse ascending: perspectives for human-disease models
000F37 Kallol Ray Chaudhuri [Royaume-Uni] ; Pablo Martinez-Martin [Espagne] ; Richard G. Brown [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie] ; Per Odin [Allemagne] ; William Ondo [États-Unis] ; Kazuo Abe [Japon] ; Graeme Macphee [Royaume-Uni] ; Doug Macmahon [Royaume-Uni] ; Paolo Barone [Italie] ; Martin Rabey [Israël] ; Alison Forbes [Royaume-Uni] ; Kieran Breen [Royaume-Uni] ; Susanne Tluk [Royaume-Uni] ; Yogini Naidu [Royaume-Uni] ; Warren Olanow [États-Unis] ; Adrian J. Williams [Royaume-Uni] ; Sue Thomas [Royaume-Uni] ; David Rye [États-Unis] ; Yoshio Tsuboi [Japon] ; Annette Hand [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni]The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study
001027 Giovanni Fabbrini [Italie] ; Jonathan M. Brotchie [Canada] ; Francisco Grandas [Espagne] ; Masahiro Nomoto [Japon] ; Christopher G. Goetz [États-Unis]Levodopa‐induced dyskinesias
001053 Ulrich R. M. Bohr [Allemagne] ; Bruno Annibale [Italie] ; Francesco Franceschi [Italie] ; Davide Roccarina [Italie] ; Antonio Gasbarrini [Italie]Extragastric Manifestations of Helicobacter pylori Infection – Other Helicobacters
001124 Annalisa Pinna [Italie] ; Silvia Pontis [Italie] ; Franco Borsini [Italie] ; Micaela Morelli [Italie]Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6‐hydroxydopamine rat model of Parkinson's disease
001196 Ioannis U. Isaias [Italie] ; Riccardo Benti [Italie] ; Stefano Goldwurm [Italie] ; Michela Zini [Italie] ; Roberto Cilia [Italie] ; Paolo Gerundini [Italie] ; Alessio Di Fonzo [Pays-Bas, Italie] ; Vincenzo Bonifati [Pays-Bas, Italie] ; Gianni Pezzoli [Italie] ; Angelo Antonini [Italie]Striatal dopamine transporter binding in Parkinson's disease associated with the LRRK2 Gly2019Ser mutation
001349 Paolo Mazzone [Italie] ; Fabrizio Stocchi [Italie] ; Salvatore Galati [Italie] ; Angelo Insola [Italie] ; Maria Grazia Altibrandi [Italie] ; Nicola Modugno [Italie] ; Domenicantonio Tropepi [Italie] ; Livia Brusa [Italie] ; Alessandro Stefani [Italie]Bilateral Implantation of Centromedian‐Parafascicularis Complex and GPi: A New Combination of Unconventional Targets for Deep Brain Stimulation in Severe Parkinson Disease
001408 S. Goldwurm [Italie] ; A Di Fonzo [Italie] ; E J Simons [Pays-Bas] ; C F Rohé [Pays-Bas] ; M. Zini [Italie] ; M. Canesi [Italie] ; S. Tesei [Italie] ; A. Zecchinelli [Italie] ; A. Antonini [Italie] ; C. Mariani [Italie] ; N. Meucci [Italie] ; G. Sacilotto [Italie] ; F. Sironi [Italie] ; G. Salani [Italie] ; J. Ferreira [Portugal] ; H F Chien [Brésil] ; E. Fabrizio [Italie] ; N. Vanacore [Italie] ; A Dalla Libera [Italie] ; F. Stocchi [Italie] ; C. Diroma [Italie] ; P. Lamberti [Italie] ; C. Sampaio [Portugal] ; G. Meco [Italie] ; E. Barbosa [Brésil] ; A M Bertoli-Avella [Pays-Bas] ; G J Breedveld [Pays-Bas] ; B A Oostra [Pays-Bas] ; G. Pezzoli [Italie] ; V. Bonifati [Pays-Bas]The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson’s disease and originates from a common ancestor
001420 Angelo Insola [Italie] ; Paolo Mazzone [Italie] ; Massimiliano Valeriani [Italie]Somatosensory evoked potential and clinical changes after electrode implant in basal ganglia of parkinsonian patients
001452 Aida M. Bertoli-Avella [Pays-Bas] ; José L. Giroud-Benitez [Cuba] ; Ali Akyol [Turquie] ; Egberto Barbosa [Brésil] ; Onno Schaap [Pays-Bas] ; Herma C. Van Der Linde [Pays-Bas] ; Emilia Martignoni [Italie] ; Leonardo Lopiano [Italie] ; Paolo Lamberti [Italie] ; Emiliana Fincati [Italie] ; Angelo Antonini [Italie] ; Fabrizio Stocchi [Italie] ; Pasquale Montagna [Italie] ; Ferdinando Squitieri [Italie] ; Paolo Marini [Italie] ; Giovanni Abbruzzese [Italie] ; Giovanni Fabbrini [Italie] ; Roberto Marconi [Italie] ; Alessio Dalla Libera [Italie] ; Giorgio Trianni [Italie] ; Marco Guidi [Italie] ; Antonio De Gaetano [Italie] ; Gustavo Boff Maegawa [Brésil] ; Antonino De Leo [Italie] ; Virgilio Gallai [Italie] ; Giulia De Rosa [Italie] ; Nicola Vanacore [Italie] ; Giuseppe Meco [Italie] ; Cornelia M. Van Duijn [Pays-Bas] ; Ben A. Oostra [Pays-Bas] ; Peter Heutink [Pays-Bas] ; Vincenzo Bonifati [Pays-Bas, Italie]Novel parkin mutations detected in patients with early‐onset Parkinson's disease
001574 Fabio Guerini [Italie] ; Giovanni B. Frisoni [Italie] ; Catherine Bellwald [Italie] ; Roberta Rossi Psy [Italie] ; Giuseppe Bellelli [Italie] ; Marco Trabucchi [Italie]Subcortical Vascular Lesions Predict Functional Recovery After Rehabilitation in Patients with L‐Dopa Refractory Parkinsonism
001595 Enza Maria Valente [Italie] ; Sergio Salvi [Italie] ; Tamara Ialongo [Italie] ; Roberta Marongiu [Italie] ; Antonio Emanuele Elia [Italie] ; Viviana Caputo [Italie] ; Luigi Romito [Italie] ; Alberto Albanese [Italie] ; Bruno Dallapiccola [Italie] ; Anna Rita Bentivoglio [Italie]PINK1 mutations are associated with sporadic early‐onset parkinsonism
001613 C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie]Levodopa in the treatment of Parkinson's disease: Current controversies
001700 Maria G. Macedo ; Burcu Anar ; Iraad F. Bronner ; Milena Cannella ; Ferdinando Squitieri ; Vincenzo Bonifati [Italie] ; Andre Hoogeveen ; Peter Heutink ; Patrizia RizzuThe DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes
001705 Aida M. Bertoli-Avella [Pays-Bas, Cuba] ; Jose L. Giroud-Benitez [Cuba] ; Vincenzo Bonifati [Italie, Pays-Bas] ; Eduardo Alvarez-Gonzalez [Cuba] ; Luis Heredero-Baute [Cuba] ; Cornelia M. Van Duijn [Pays-Bas] ; Peter Heutink [Pays-Bas]Suggestive linkage to chromosome 19 in a large Cuban family with late‐onset Parkinson's disease
001736 Fabrizio Stocchi [Italie] ; C. Warren Olanow [États-Unis]Neuroprotection in Parkinson's disease: Clinical trials
001757 Ebba Lohmann [France] ; Magali Periquet [France] ; Vincenzo Bonifati [Italie] ; Nick W. Wood [Royaume-Uni] ; Giuseppe De Michele [Italie] ; Anne-Marie Bonnet [France] ; Valérie Fraix [France] ; Emmanuel Broussolle [France] ; Martin W. I. M. Horstink [Pays-Bas] ; Marie Vidailhet [France] ; Patrice Verpillat [France] ; Thomas Gasser [Allemagne] ; David Nicholl [Royaume-Uni] ; Hélio Teive [Brésil] ; Salmo Raskin [Brésil] ; Olivier Rascol [France] ; Alain Destée [France] ; Merle Ruberg [France] ; Francesca Gasparini [France] ; Giuseppe Meco [Italie] ; Yves Agid [France] ; Alexandra Durr [France] ; Alexis Brice [France]How much phenotypic variation can be attributed to parkin genotype?
001784 A. Albanese [Italie] ; C. Colosimo [Italie]Dihydroergocriptine in Parkinson's disease: clinical efficacy and comparison with other dopamine agonists
001827 K R Chaudhuri [Royaume-Uni] ; S. Pal [Royaume-Uni] ; A. Dimarco [Royaume-Uni] ; C. Whately-Smith ; K. Bridgman [Royaume-Uni] ; R. Mathew [Royaume-Uni] ; F R Pezzela [Italie] ; A. Forbes [Royaume-Uni] ; B. Högl [Allemagne] ; C. Trenkwalder [Allemagne]The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease
001894 Fabrizio Drago [Italie] ; Massimo Stefano Silvetti [Italie] ; Alfredo Di Pino [Italie] ; Giorgia Grutter [Italie] ; Maurizio Bevilacqua [Italie] ; Shoshana Leibovich [Italie]Exclusion of Fluoroscopy During Ablation Treatment of Right Accessory Pathway in Children
001895 Giovanni Fabbrini [Italie] ; Piero Barbanti [Italie] ; Cinzia Aurilia [Italie] ; Nicola Vanacore [Italie] ; Caterina Pauletti [Italie] ; Giuseppe Meco [Italie]Excessive daytime sleepiness in de novo and treated Parkinson's disease
001902 Olivia Leoni [Italie] ; Emilia Martignoni [Italie] ; Marco Cosentino [Italie] ; Donatella Michielotto [Italie] ; Daniela Calandrella [Italie] ; Roberta Zangaglia [Italie] ; Giulio Riboldazzi [Italie] ; Cristina Oria [Italie] ; Sergio Lecchini [Italie] ; Giuseppe Nappi [Italie] ; Gianmario Frigo [Italie]Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients
001A34 Anna R. Bentivoglio [Italie] ; Pietro Cortelli [Italie] ; Enza M. Valente [Italie] ; Tàmara Ialongo [Italie] ; Alessandro Ferraris [Italie] ; Antonio Elia [Italie] ; Pasquale Montagna [Italie] ; Alberto Albanese [Italie]Phenotypic characterisation of autosomal recessive PARK6‐linked parkinsonism in three unrelated Italian families
001A48 Enza Maria Valente [Royaume-Uni] ; Anna Rita Bentivoglio [Italie] ; Peter H. Dixon [Royaume-Uni] ; Alessandro Ferraris [Italie] ; Tamara Ialongo [Italie] ; Marina Frontali [Italie] ; Alberto Albanese [Italie] ; Nicholas W. Wood [Royaume-Uni]Localization of a Novel Locus for Autosomal Recessive Early-Onset Parkinsonism, PARK6, on Human Chromosome 1p35-p36
001A90 Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie]Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease
001D74 Gambassi [Italie, États-Unis] ; Landi [Italie] ; Lapane [États-Unis] ; Sgadari [Italie] ; Mor [États-Unis] ; Bernabei [Italie]Is Drug Use by the Elderly with Cognitive Impairment Influenced by Type of Dementia?
001E40 P. Stanzione [Italie] ; R. Semprini [Italie] ; M. Pierantozzi [Italie] ; A. M Santilli [Italie] ; L. Fadda [Italie] ; R. Traversa [Italie] ; A. Peppe [Italie] ; G. Bernardi [Italie]Age and stage dependency of P300 latency alterations in non-demented Parkinson's disease patients without therapy
001E63 Rascol [France] ; David J. Brooks [Royaume-Uni] ; Ehrout R. Brunt [Pays-Bas] ; Amos D. Korczyn [Israël] ; Warner H. Poewe [Autriche] ; Fabrizzio Stocchi [Italie]Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled study
001E74 R. Raschetti [Italie] ; S. Spila-Alegiani [Italie] ; N. Vanacore [Italie] ; C. Ancona [Italie] ; G. Meco [Italie]Mortality in a population‐based cohort of patients treated with antiparkinsonian drugs
001F94 P. Stanzione [Italie] ; R. Traversa [Italie] ; M. Pierantozzi [Italie] ; R. Semprini [Italie] ; M. Loberti [Italie] ; A. Peppe [Italie] ; A. M. Santilli [Italie] ; G. Bernardi [Italie]SEPs N30 amplitude in Parkinson's disease and in pharmacologically induced rigidity: relationship with the clinical status
002239 Paolo M. Rossini [Italie] ; M. Antonietta Bassetti [Italie] ; Patrizio Pasqualetti [Italie]Median nerve somatosensory evoked potentials. Apomorphine-induced transient potentiation of frontal components Clin. Parkinson's disease and in parkinsonism
002349 Annibale Sandro Montenero [Italie] ; Filippo Crea [Italie] ; Maria Grazia Bendini [Italie] ; Fulvio Bellocci [Italie] ; Paolo Zecchi [Italie]Catheter Ablation of Left Accessory Atrioventricular Connections: The Transseptal Approach
002382 A. Priori [Italie] ; A. Berardelli [Italie] ; M. Inghilleri [Italie] ; N. Accornero [Italie] ; M. Manfredi [Italie]Motor cortical inhibition and the dopaminergic system
002548 Milena De Marinis [Italie] ; Guido Argenta [Italie] ; Domenico Mele [Italie] ; Antonio Carbone [Italie] ; Giulio Baffigo [Italie] ; Alessandro Agnoli [Italie]Evaluation of vesico-urethral and sweating function in disorders presenting with parkinsonism
002564 Giovanni Diana [Italie] ; Stefania Spila Alegiani [Italie] ; Marco Fortini [Italie] ; Roberto [Italie] ; Roberto Raschetti [Italie]Anticholinergic anti‐Parkinson drug prescription in haloperidol‐treated patients: A population‐based study
002701 G. Cusimano [Italie] ; C. Capriani [Italie] ; V. Bonifati [Italie] ; G. Meco [Italie]Hypothalamo‐pituitary function and dopamine dependence in untreated parkinsonian patients
002713 R. Fenici [Italie] ; Guido Melillo [Italie] ; Mariella Masselli [Italie]Clinical magnetocardiography
002717 Giuseppe Meco [Italie] ; Luca Pratesi [Italie] ; Vincenzo Bonifati [Italie]Cardiovascular reflexes and autonomic dysfunction in parkinson's disease
002873 M. M. Mouradian [États-Unis] ; J. L. Junecos [États-Unis] ; G. Fabbrini [États-Unis, Italie] ; J. Schlegel [États-Unis] ; J. J. Bartko [États-Unis] ; Chase [États-Unis]Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, part II
002874 G. Fabbnni [États-Unis, Italie] ; M. M. Mouradian [États-Unis] ; J. L. Junecos [États-Unis] ; J. Schlegel [États-Unis] ; E. Mohr [États-Unis] ; Chase [États-Unis]Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, Part I

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024